Comments on "Critical aspects of the Bayesian approach to phase I cancer trials"
Stat Med
.
2020 Nov 30;39(27):4100.
doi: 10.1002/sim.8483.
Authors
Xiang Li
1
,
Kevin Liu
1
,
Hong Tian
1
Affiliation
1
Statistics and Decision Sciences, Janssen Research & Development, LLC, Raritan, New Jersey.
PMID:
33165948
DOI:
10.1002/sim.8483
No abstract available
Publication types
Letter
Comment
MeSH terms
Bayes Theorem
Humans
Neoplasms* / drug therapy
Research Design